In industries where strict regulatory requirements govern the integrity of electronic records and signatures, such as pharmaceuticals, biotechnology, and healthcare, ensuring the security of sensitive data is paramount. 21 CFR Part 11, issued by the FDA, outlines the rules for Read more…
